Ethicomedicolegal aspects of the COVID-19 health services in preparing regulations and intermediaries for clinical dispute resolution: a systematic review
Abstract
BACKGROUND The COVID-19 pandemic has caused many medical, ethical, and medicolegal changes, including constant adjustments in service guidelines. Continuing to revise healthcare regulations and guidelines can potentially cause clinical disputes or medical negligence that require ethical and legal solutions. This study aimed to determine the ethical and medicolegal aspects of the potential factors that cause clinical disputes during the pandemic and provide anticipative solutions to national ethicomedicolegal policies.
METHODS A systematic literature search in PubMed, ScienceDirect, ClinicalKey, and Google Scholar was performed using keywords “clinical dispute,” “ethics,” “medicolegal,” “ethicolegal,” and “COVID-19”. The inclusion criteria were articles that contained information on shortage, justice, ethical distribution in intensive care, the possibility of lawsuits and disputes among stakeholders during the pandemic, and stakeholders’ roles in managing the pandemic. Key evidence was analyzed and synthesized following national ethicomedicolegal policies.
RESULTS We identified 19 articles from the 4 databases. Based on the literature, the main ethicomedicolegal impact of the COVID-19 pandemic appears in 3 aspects: (1) a shortage of fair and ethical intensive care services with fair and ethical distribution efforts, (2) legal protection for medical personnel from legal charges while providing health services during the pandemic, and (3) the government’s role in managing the pandemic together with the stakeholders involved.
CONCLUSIONS Ethicomedicolegal clinical dispute management and its norms require an update, especially when deciding the complexity of COVID-19 service standards. Ethicomedicolegal professionals are needed as intermediaries to manage cases of clinical disputes and to implement fair malpractice criteria in Indonesia.
References
World Health Organization regional Office for Europe. Coronavirus disease (COVID-19) pandemic. Copenhagen: World Health Organization Regional Office for Europe. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov#.
President of the Republic of Indonesia. Decree of the President of the Republic of Indonesia number 12 of 2020 concerning the determination of non-natural disasters spreading of corona virus disease 2019 (COVID-19) as a national disaster [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135718/keppres-no-12-tahun-2020. Indonesian.
President of the Republic of Indonesia. Government Regulation of the Republic of Indonesia number 21 of 2020 concerning large-scale social restrictions in the context of accelerating handling of corona virus disease 2019 (COVID-19) [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135059/pp-no-21-tahun-2020. Indonesian.
President of the Republic of Indonesia. Government Regulation in Lieu of Law of the Republic of Indonesia number 1 of 2020 concerning state financial policy and financial system stability for handling the COVID-19 pandemic and/or in facing threats which endanger the national economy [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135060/perpu-no-1-tahun-2020. Indonesian.
President of the Republic of Indonesia. Decree of the President of the Republic of Indonesia number 11 of 2020 concerning the determination of public health emergency of corona virus disease 2019 (COVID-19) [Internet]. 2020. Available from: https://peraturan.bpk.go.id/Home/Details/135058/keppres-no-11-tahun-2020. Indonesian.
Ministry of Health of the Republic of Indonesia. Guidelines for the prevention and control of coronavirus disease (COVID-19) [Internet]. Jakarta: Directorate General of Disease Prevention and Control; 2020. Available from: https://infeksiemerging.kemkes.go.id/download/KMK_No._HK.01.07-MENKES-413-2020_ttg_Pedoman_Pencegahan_dan_Pengendalian_COVID-19.pdf. Indonesian.
Tolentino VR, Derevlany L, DeLaMothe C, Vick S, Chalyavski L. The effects of the COVID-19 pandemic on risk management practice: a report from the epicenter of the epicenter in New York City. J Healthc Risk Manag. 2021;40(4):46-57. https://doi.org/10.1002/jhrm.21461
Cook T, Gupta K, Dyer C, Fackrell R, Wexler S, Boyes H, et al. Development of a structured process for fair allocation of critical care resources in the setting of insufficient capacity: a discussion paper. J Med Ethics. 2020;47(7):456-63. https://doi.org/10.1136/medethics-2020-106771
Riyanto OS, Ardyantara DM, Wardhana RS, Lungan L. Legal protection for doctors against dishonesty of patients in providing information during COVID-19 pandemic. Int J Sci Technol Manag. 2021;2(1):289-99. https://doi.org/10.46729/ijstm.v2i1.118
Duignan K, Bradbury C. Covid-19 and medical negligence litigation: immunity for healthcare professionals? Med Leg J. 2020;88(1_suppl):31-4. https://doi.org/10.1177/0025817220935892
Riley-Smith Qc T, Heppinstall A, Foster F. Is Covid-19 sowing the seeds for future litigation? Med Leg J. 2020;88(2):90-7. https://doi.org/10.1177/0025817220926943
Marshall AI, Archer R, Witthayapipopsakul W, Sirison K, Chotchoungchatchai S, Sriakkpokin P, et al. Developing a Thai national critical care allocation guideline during the COVID-19 pandemic: a rapid review and stakeholder consultation. Health Res Policy Sys. 2021;19(47). https://doi.org/10.1186/s12961-021-00696-z
Sesta L, Mondello C, Cardia L, Modello E, Baldino G, Spagnolo EV. COVID-19 in Italy. Clinical emergency and bioethical perspectives. EuroMediterranean Biomed J. 2020;15(30):121-5. https://doi.org/10.3269/1970-5492.2020.15.30
Netters S, Dekker N, van de Wetering K, Hasker A, Paasman D, de Groot JW, et al. Pandemic ICU triage challenge and medical ethics. BMJ Support Palliat Care. 2021;11(2):133-7. https://doi.org/10.1136/bmjspcare-2020-002793
Bolcato M, Aurilio MT, Aprile A, Di Mizio G, Della Pietra B, Feola A. Take-home messages from the COVID-19 pandemic: strengths and pitfalls of the Italian National Health Service from a medico-legal point of view. Healthcare (Basel). 2020;9(1):17. https://doi.org/10.3390/healthcare9010017
Mehta AR, Szakmany T, Sorbie A. The medicolegal landscape through the lens of COVID-19: time for reform. J R Soc Med. 2021;114(2):55-9. https://doi.org/10.1177/0141076820974988
Oliva A, Caputo M, Grassi S, Vetrugno G, Marazza M, Ponzanelli G, et al. Liability of health care professionals and institutions during COVID-19 pandemic in Italy: symposium proceedings and position statement. J Patient Saf. 2020;16(4):e299-302. https://doi.org/10.1097/PTS.0000000000000793
Barranco R, Vallega Bernucci Du Tremoul L, Ventura F. Hospital-acquired SARS-Cov-2 infections in patients: inevitable conditions or medical malpractice? Int J Environ Res Public Health. 2021;18(2):489. https://doi.org/10.3390/ijerph18020489
Ferorelli D, Mandarelli G, Solarino B. Ethical challenges in health care policy during COVID-19 pandemic in Italy. Medicina (Kaunas). 2020;56(12):691. https://doi.org/10.3390/medicina56120691
Kumar A, Kapila M, Pankaj R. Medicine and law in the times of COVID-19 pandemic: understanding the interphase. Indian J Crit Care Med. 2020;24(10):971-4. https://doi.org/10.5005/jp-journals-10071-23553
Coghlan N, Archard D, Sipanoun P, Hayes T, Baharlo B. COVID-19: legal implications for critical care. Anaesthesia. 2020;75(11):1517- 28. https://doi.org/10.1111/anae.15147
Bonvicini B, Cecchi R, Parisi SG, Masotti V, Viero A, Cecchetto G, et al. Legal scenarios in the coronavirus time: medico legal implications in the aspects of governance. Leg Med (Tokyo). 2021;48:101832. https://doi.org/10.1016/j.legalmed.2020.101832
Camporesi S, Mori M. Ethicists, doctors and triage decisions: who should decide? And on what basis? J Med Ethics. 2020;47:e18. https://doi.org/10.1136/medethics-2020-106499
Arimany-Manso J, Martin-Fumadó C. [Medico-legal issues regarding from the COVID-19 pandemic]. Med Clin (Barc). 2020;155(8):344-6. English, Spanish. https://doi.org/10.1016/j.medcle.2020.06.014
Kelly AM. COVID-19 and medical litigation: more than just the obvious. Emerg Med Australas. 2020;32(4):703-5. https://doi.org/10.1111/1742-6723.13548
Sugiharto AF, Purwadianto A, Madjid AS, Budiningsih Y. [Distributive justice in intensive care: ethicolegal review in the reposition of doctor-patient treating relationship] [dissertation]. Jakarta: Universitas Indonesia; 2018. Indonesian.
Riva L, Petrini C. Ethics of triage for intensive-care interventions during the COVID-19 pandemic: age or disability related cut-off policies are not justifiable. Clin Ethics. 2021;16(3):228-33. https://doi.org/10.1177/1477750920971803
Gostin LO. Pandemic Influenza: public health preparedness for the next global health emergency. J Law Med Ethics. 2004;32(4):565-73. https://doi.org/10.1111/j.1748-720X.2004.tb01962.x
Xavier F. Disciplinary proceedings in the medical profession: part I. Singapore: Rajah & Tann Publication; 2000.
American Medical Association. COVID-19: recommendations for pursuing liability protections through state action [Internet]. American Medical Association; 2020. Available from: https://www.ama-assn.org/system/files/2020-04/state-guidance-medical-liability-protections.pdf.
Budiningsih Y. [The methodological foundation of ethical decision doctor mediators in preventing and resolving medical dispute] [dissertation]. Jakarta: Universitas Indonesia; 2012. Indonesian.
Brown DK. Criminal procedure entitlements, professionalism, and lawyering norms. SSRN Electronic Journal. 2000;61(2):867-8. https://doi.org/10.2139/ssrn.247337
Kyriakakis J. Developments in international criminal law and the case of business involvement in international crimes. International Review of the Red Cross. 2012;94(887):981-1005. https://doi.org/10.1017/S1816383113000519
Copyright (c) 2022 Agus Purwadianto, Ade Firmansyah Sugiharto, Fitri Ambar Sari, Roberia, Uud Cahyono, Yuli Budiningsih, Denys Putra Alim, Nadia Ulfah Faddila
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.